Weight-loss market to see 16 new drugs by 2029, report estimates

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab, according to estimates from analysts at Morningstar and Pitchbook.